trending Market Intelligence /marketintelligence/en/news-insights/trending/fNViiYlk4fHNRRf5sHvqOw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Grifols gets US FDA green light for blood testing system

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Grifols gets US FDA green light for blood testing system

Grifols SA obtained approval from the U.S. Food and Drug Administration for Erytra Eflexis, its benchtop analyzer for blood testing.

The system uses Grifols' DG Gel technology to ensure that the blood of a transfusion recipient and the donor are compatible.

Erytra Eflexis, which received the European Commission's CE Mark in June 2017, can be used as a stand-alone system or in combination with other Grifols blood typing portfolio solutions, the Spanish healthcare company said.